Journal of the American College of Cardiology
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)
Randomised trial in 706 peopleHeart failure
Papers by A. McConnachie
3 results
- ADA Scientific Sessions 2026 Abstract
The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF
Trial in peopleBiomarkers - ADA Scientific Sessions 2026 Abstract
Triple Therapy for Type 1 Diabetes with Insulin, Semaglutide, and Dapagliflozin (TTT1): A Phase 3 Clinical Trial
Trial in peopleInterventions